[HLA-DR in patients with systemic lupus erythematosus with anti-ribonucleoprotein antibodies and in mixed connective tissue disease].
D000293:Adolescent; D000328:Adult; D000974:Antibodies, Antinuclear / Q000276:immunology*; D002648:Child; D005260:Female; D006684:HLA-DR Antigens; D000949:Histocompatibility Antigens Class II / Q000235:genetics / Q000276:immunology*; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000235:genetics / Q000276:immunology*; D008875:Middle Aged; D008947:Mixed Connective Tissue Disease / Q000235:genetics / Q000276:immunology*; D010641:Phenotype; D012261:Ribonucleoproteins / Q000276:immunology*
D000974:Antibodies, Antinuclear; D006684:HLA-DR Antigens; D000949:Histocompatibility Antigens Class II; D012261:Ribonucleoproteins
HLA-DR em portadores de lúpus eritematoso sisêmico com anticorpos anti-ribonucleoproteína e na doença mista do tecido conectivo.